Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
7Activity
0 of .
Results for:
No results containing your search query
P. 1
H1N1 Flu Vaccine is Toxic

H1N1 Flu Vaccine is Toxic

Ratings: (0)|Views: 6,738 |Likes:
Published by Info_scribd
www.fightbackh1n1.com

The willful use of toxic substances known to cause injury and death in a vaccine or injection is prohibited. The prohibition of such use is a universally accepted as a part of national and international law.

There is scientific evidence that the swine flu vaccine, especially the adjuvants, specifically squalene, cause serious injury and death.

Adjuvants have not been approved by the FDA for use in the USA .

According to Dr. Meryl Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U. S. Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U. S. vaccine, despite its history of use in other countries.

A 2000 study published in the American Journal of Pathology demonstrated a single injection of the adjuvant squalene into rats triggered “chronic, immune-mediated joint-specific inflammation,” also known as rheumatoid arthritis.
www.fightbackh1n1.com

The willful use of toxic substances known to cause injury and death in a vaccine or injection is prohibited. The prohibition of such use is a universally accepted as a part of national and international law.

There is scientific evidence that the swine flu vaccine, especially the adjuvants, specifically squalene, cause serious injury and death.

Adjuvants have not been approved by the FDA for use in the USA .

According to Dr. Meryl Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U. S. Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U. S. vaccine, despite its history of use in other countries.

A 2000 study published in the American Journal of Pathology demonstrated a single injection of the adjuvant squalene into rats triggered “chronic, immune-mediated joint-specific inflammation,” also known as rheumatoid arthritis.

More info:

Published by: Info_scribd on Aug 22, 2009
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOCX, PDF, TXT or read online from Scribd
See more
See less

02/07/2013

pdf

text

original

 
Evidence that the "H1N1 Flu"vaccine is toxic, especially theadjuvant Squalene
T
he willful use of toxic substances known tocause injury and death in a vaccine or injection is prohibited. The prohibition of such use is auniversally accepted as a part of national andinternational law.There is scientific evidence that the swine fluvaccine, especially the adjuvants, specificallysqualene, cause serious injury and death.
Adjuvants have not been approved by the FDAfor use in the USA .
According to Dr. Meryl Nass, there are only threevaccines in existence using an approved squaleneadjuvant. None of the three are approved for use inthe U. S. Novartis’s proprietary squalene adjuvantfor their H1N1 vaccine is MF59. Glaxo’s is ASO3.MF59 has yet to be approved by the FDA for usein any U. S. vaccine, despite its history of use inother countries.A 2000 study published in the American Journal of Pathology demonstrated a single injection of theadjuvant squalene into rats triggered “chronic,immune-mediated joint-specific inflammation,”also known as rheumatoid arthritis.Specific evidence of the dangers of the swine fluvaccine with adjuvants, especially squalene,include
The UK Health Protection Agencywarnied that the "swine flu" vaccine couldcause neurological damage in a letter leaked to The Mail on Sunday, a UK newspaper, which was not made public.Dr Mercola explains: "Gulf War veterans with Gulf War Syndrome (GWS) received anthrax vaccineswhich contained squalene. [ix] MF59 (the Novartissqualene adjuvant) was an unapproved ingredientin experimental anthrax vaccines and has since been linked to the devastating autoimmunediseases suffered by countless Gulf War vets. [x]The Department of Defense made every attempt todeny that squalene was indeed an addedcontaminant in the anthrax vaccine administered toPersian Gulf war military personnel – deployedand non-deployed – as well as participants in themore recent Anthrax Vaccine ImmunizationProgram (AVIP).However, the FDA discovered the presence of squalene in certain lots of AVIP product. A test wasdeveloped to detect anti-squalene antibodies inGWS patients, and a clear link was established between the contaminated product and all theGWS sufferers who had been injected with thevaccine containing squalene.A study conducted at Tulane Medical School and published in the February 2000 issue oExperimental Molecular Pathology included thesestunning statistics:“ … the substantial majority (95%) of overtly illdeployed GWS patients had antibodies tosqualene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did notdeploy, but had the same signs and symptoms asthose who did deploy, had antibodies to squalene.In contrast, none (0%) of the deployed PersianGulf veterans not showing signs and symptoms of GWS have antibodies to squalene. Neither patientswith idiopathic autoimmune disease nor healthycontrols had detectable serum antibodies tosqualene. The majority of symptomatic GWS patients had serum antibodies to squalene.”[xi]
Adjuvants are used in vaccines designedto impair fertility in animals according to patents.WO/1999/034825) FERTILITY IMPAIRINGVACCINE AND METHOD OF USE Thisapplication claims the benefit of U. S. ProvisionalApplication No. 60/070,375, filed January 2,1998,U. S. Provisional Application No. 60/071,406,filed January 15,1998 “The vaccine of theinvention preferably additionally includes animmunological adjuvant to enhance the
 
immunological response of the subject to theglycoprotein antigen. Examples of adjuvantsinclude Freund’s Complete Adjuvant, Freund’sIncomplete Adjuvant, and an adjuvant comprisingan immunostimulant such as synthetic trehalosedicorynomycolate (STDCM) and an oil such assqualene oil (see P. Willis et al., J. Equine Vet. Sci.,14,364-370 (1994)). An adjuvant comprisingsynthetic trehalose dicorynemycolate, squalene oil,and a surfactant such as lecithin is preferred.Lecithin typically includes phosphatidyl choline.In a preferred embodiment the vaccine comprisesoil, preferably a biodegradable oil such as squaleneoil. Typically, the vaccine is prepared using anadjuvant concentrate which contains lecithin insqualene oil. The aqueous solution glycoprotein istypically a phosphate-buffered saline (PBS)solution, and additionally preferably containsTween 80.”
There is clear evidence all vaccinationsare bad and that vaccine companies have been involved in concealing the dangersfrom us by systematically manipulatingdata. Dr Rebecca carley, court qualifiedexpert on vaccines, has calledinnoculations, the true weapons of massdestruction.In spite of the scientific evidence that vaccines,especially those with adjuvants, particularlysqualene, are dangerous, the WHO prescribed byvirtue of the authority vested in it by itsConstitution and the International HealthRegulations 2005 that vaccinations against theswine flu must contain adjuvants.Scientific evidence offers proof that adjuvants suchas squalene are dangerous just as there issubstantial proof a loaded gun will be dangerouswhen fired at you without getting hold of thespecific bullets and exminaing them in a lab - andyet the WHO choses to include that dangeroussubstance even though vaccine company's own published clinical trials show that adjuvants aredeletrious.
Reports in full length
The report in the Mail on Sunday: Swineflu jab link to killer nerve disease: Leakedletter reveals concern of neurologists over 25 deaths in AmericaBy Jo Macfarlane Last updated at 11:05 PM on15th August 2009
Prevention: Is the swine flu jab safe?
A warning that the new swine flu jab is linked to adeadly nerve disease has been sent by theGovernment to senior neurologists in aconfidential letter.The letter from the Health Protection Agency, theofficial body that oversees public health, has beenleaked to The Mail on Sunday, leading to demandsto know why the information has not been given tothe public before the vaccination of millions of  people, including children, begins.It tells the neurologists that they must be alert for an increase in a brain disorder called Guillain-Barre Syndrome (GBS), which could be triggered by the vaccine.GBS attacks the lining of the nerves, causing paralysis and inability to breathe, and can be fatal.The letter, sent to about 600 neurologists on July29, is the first sign that there is concern at thehighest levels that the vaccine itself could causeserious complications.It refers to the use of a similar swine flu vaccine inthe United States in 1976 when:* More people died from the vaccination than fromswine flu. * 500 cases of GBS were detected. *The vaccine may have increased the risk of contracting GBS by eight times. * The vaccinewas withdrawn after just ten weeks when the link with GBS became clear. * The US Governmentwas forced to pay out millions of dollars to thoseaffected.Concerns have already been raised that the newvaccine has not been sufficiently tested and thatthe effects, especially on children, are unknown.
 
It is being developed by pharmaceutical companiesand will be given to about 13million people duringthe first wave of immunisation, expected to start inOctober.Top priority will be given to everyone aged sixmonths to 65 with an underlying health problem, pregnant women and health professionals.The British Neurological Surveillance Unit(BNSU), part of the British Association of  Neurologists, has been asked to monitor closelyany cases of GBS as the vaccine is rolled out.One senior neurologist said last night: ‘I would nothave the swine flu jab because of the GBS risk.’There are concerns that there could be a repeat of what became known as the ‘1976 debacle’ in theUS, where a swine flu vaccine killed 25 people – more than the virus itself.A mass vaccination was given the go-ahead byPresident Gerald Ford because scientists believedthat the swine flu strain was similar to the oneresponsible for the 1918-19 pandemic, whichkilled half a million Americans and 20million people worldwide.The swine flu vaccine being offered to children hasnot been tested on infantsWithin days, symptoms of GBS were reportedamong those who had been immunised and 25 people died from respiratory failure after severe paralysis. One in 80,000 people came down withthe condition. In contrast, just one person died of swine flu.More than 40million Americans had received thevaccine by the time the programme was stoppedafter ten weeks. The US Government paid outmillions of dollars in compensation to thoseaffected.The swine flu virus in the new vaccine is a slightlydifferent strain from the 1976 virus, but the possibility of an increased incidence of GBSremains a concern.Shadow health spokesman Mike Penning said lastnight: ‘The last thing we want is secret lettershanded around experts within the NHS. We need avaccine but we also need to know about potentialrisks.‘Our job is to make sure that the public knowswhat’s going on. Why is the Government not beingopen about this? It’s also very worrying if GPs,who will be administering the vaccine, aren’t beingwarned.’Two letters were posted together to neurologistsadvising them of the concerns. The first, dated July29, was written by Professor Elizabeth Miller, headof the HPA’s Immunisation Department.It says: ‘The vaccines used to combat an expectedswine influenza pandemic in 1976 were shown to be associated with GBS and were withdrawn fromuse.‘GBS has been identified as a condition needingenhanced surveillance when the swine flu vaccinesare rolled out.‘Reporting every case of GBS irrespective of vaccination or disease history is essential foconducting robust epidemiological analysescapable of identifying whether there is anincreased risk of GBS in defined time periods after vaccination, or after influenza itself, comparedwith the background risk.’The second letter, dated July 27, is from theAssociation of British Neurologists and is written by Dr Rustam Al-Shahi Salman, chair of itssurveillance unit, and Professor Patrick Chinnery,chair of its clinical research committee.Halted: The 1976 US swine flu campaignIt says: ‘Traditionally, the BNSU has monitoredrare diseases for long periods of time. However,the swine influenza (H1N1) pandemic hasovertaken us and we need every member’sinvolvement with a new BNSU survey of Guillain-Barre Syndrome that will start on August 1 and runfor approximately nine months.‘Following the 1976 programme of vaccinationagainst swine influenza in the US, a retrospectivestudy found a possible eight-fold increase in theincidence of GBS.

Activity (7)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads
hanna_ali liked this
nelly1 liked this
go2jie liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->